Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

United Therapeutics (UTHR) Intangibles (2016 - 2020)

United Therapeutics (UTHR) has disclosed Intangibles for 10 consecutive years, with $128.9 million as the latest value for Q1 2020.

  • Quarterly Intangibles rose 7956.25% to $128.9 million in Q1 2020 from the year-ago period, while the trailing twelve-month figure was $128.9 million through Mar 2020, up 7956.25% year-over-year, with the annual reading at $1.4 million for FY2019, 79.1% down from the prior year.
  • Intangibles hit $128.9 million in Q1 2020 for United Therapeutics, up from $1.4 million in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $128.9 million in Q2 2019 to a low of $400000.0 in Q3 2016.
  • Historically, Intangibles has averaged $22.0 million across 5 years, with a median of $1.7 million in 2016.
  • Biggest five-year swings in Intangibles: crashed 97.42% in 2016 and later skyrocketed 7956.25% in 2020.
  • Year by year, Intangibles stood at $1.7 million in 2016, then skyrocketed by 1688.24% to $30.4 million in 2017, then crashed by 77.96% to $6.7 million in 2018, then crashed by 79.1% to $1.4 million in 2019, then soared by 9107.14% to $128.9 million in 2020.
  • Business Quant data shows Intangibles for UTHR at $128.9 million in Q1 2020, $1.4 million in Q4 2019, and $1.5 million in Q3 2019.